Skip to main content

Health: Coronary Care

Volume 696: debated on Wednesday 5 December 2007

asked Her Majesty's Government:

What plans they have to assess the impact on the ability of the National Health Service to meet an 18-week waiting-time target for coronary artery bypass surgery should the National Institute for Health and Clinical Excellence's decision not to recommend treatment with drug-eluting stents in the National Health Service be upheld; and [HL582]

In the light of the National Institute for Health and Clinical Excellence's decision not to recommend treatment with drug-eluting stents in the National Health Service, what advice they will give to primary care trusts which find their budgetary provision for coronary artery bypass surgery is inadequate as a result of increased demand. [HL583]

The National Institute for Health and Clinical Excellence (NICE) is reviewing its October 2003 guidance on the use of drug-eluting stents for the treatment of coronary artery disease. NICE is currently considering the responses it has received from stakeholders during the recent consultation on its draft recommendations. I understand that NICE expects to publish final guidance in March 2008. In the mean time, the recommendations in its original appraisal continue to apply.